US Map / Kentucky
State KY

Clinical Trials in Kentucky

Kentucky is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Kentucky and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 163 actively recruiting studies with Kentucky sites out of 163 registered in total. The busiest research areas in Kentucky are Colorectal Cancer, Ovarian Cancer, Hypertension. Leading sponsors running trials in the state include National Cancer Institute (NCI), University of Louisville, SWOG Cancer Research Network. By stage, Kentucky trials break down as Phase 1 (21), Phase 2 (49), Phase 3 (59), Phase 4 (8).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
163
Recruiting Now
163
← Back to US Map
Top Conditions in Kentucky
Colorectal Cancer (4)Ovarian Cancer (3)Hypertension (3)Obesity (3)Non-small Cell Lung Cancer (3)Stage III Pancreatic Cancer AJCC v8 (3)Spinal Cord Injuries (3)Acute Myeloid Leukemia (3)Heart Failure (2)Endometrial Cancer (2)NSCLC (2)Renal Insufficiency (2)

Frequently Asked Questions — Clinical Trials in Kentucky

How many clinical trials are currently recruiting in Kentucky?
ClinicalMetric currently tracks 163 actively recruiting clinical trials with at least one location in Kentucky. The total number of registered studies—including active but not currently enrolling trials—is 163. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Kentucky?
Kentucky hosts clinical trials across a broad range of medical conditions, including Colorectal Cancer, Ovarian Cancer, Hypertension, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Kentucky serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Kentucky?
To join a clinical trial in Kentucky, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Kentucky maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Kentucky

NCT06773910 Phase 2
Recruiting
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lu...
Condition
Limited Stage Small Cell Lung Cancer
Enrollment
250 pts
Location
United States
Sponsor
SCRI Development Innovations,
View Trial →
NCT05391126 N/A
Recruiting
GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Ver...
Condition
Colorectal Cancer
Enrollment
178 pts
Location
United States
Sponsor
Reema A. Patel
View Trial →
NCT05493215 Phase 2
Recruiting
Imatinib TDM in GIST
Condition
Gastrointestinal Stromal Tumors
Enrollment
28 pts
Location
United States
Sponsor
Reema A. Patel
View Trial →
NCT06276452 N/A
Recruiting
Supporting Resilience Among Re-entered Seniors
Condition
Chronic Disease
Enrollment
8 pts
Location
United States
Sponsor
University of Louisville
View Trial →
NCT06617325 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Part...
Condition
Systemic Lupus Erythematosus
Enrollment
450 pts
Location
United States, Argentina, Belgium
Sponsor
UCB Biopharma SRL
View Trial →
NCT06979362 Phase 2
Recruiting
A Research Study Comparing Different Doses of CDR132L With Placebo on the Struct...
Condition
Heart Failure
Enrollment
200 pts
Location
United States, Canada, Germany
Sponsor
Novo Nordisk A/S
View Trial →
NCT05103683 Phase 1
Recruiting
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
Condition
Advanced Solid Tumor
Enrollment
90 pts
Location
United States, South Korea
Sponsor
TORL Biotherapeutics, LLC
View Trial →
NCT03481283 N/A
Recruiting
A Causative Role for Amylin in Diabetic Peripheral Neuropathy
Condition
Type2 Diabetes
Enrollment
40 pts
Location
United States
Sponsor
Zabeen Mahuwala, MD
View Trial →
NCT03723928 N/A
Recruiting
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Re...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
739 pts
Location
United States, Guam, Puerto Rico
Sponsor
SWOG Cancer Research Network
View Trial →
NCT05828511 Phase 1, Phase 2
Recruiting
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerat...
Condition
Multiple Myeloma
Enrollment
149 pts
Location
United States, France, Spain
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT04166409 Phase 3
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients Wit...
Condition
Low Grade Astrocytoma
Enrollment
170 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07165028 Phase 3
Recruiting
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associ...
Condition
Metabolic Dysfunction-Associated Steatotic Liver Disease
Enrollment
4,500 pts
Location
United States, Argentina, Australia
Sponsor
Eli Lilly and Company
View Trial →
NCT06324201 N/A
Recruiting
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use i...
Condition
Paroxysmal Atrial Fibrillation
Enrollment
250 pts
Location
United States
Sponsor
Heart Rhythm Clinical and Rese
View Trial →
NCT05915299 N/A
Recruiting
US National OCS Heart Perfusion (OHP) Registry
Condition
Heart Transplant
Enrollment
100,000 pts
Location
United States
Sponsor
TransMedics
View Trial →
NCT06059638 N/A
Recruiting
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Condition
Hypertension
Enrollment
316 pts
Location
United States, Australia, Belgium
Sponsor
Orchestra BioMed, Inc
View Trial →
NCT05568550 Phase 2
Recruiting
Pembro With Radiation With or Without Olaparib
Condition
Prostate Cancer
Enrollment
64 pts
Location
United States
Sponsor
Zin W Myint
View Trial →
NCT06393374 Phase 3
Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did ...
Condition
Triple-Negative Breast Cancer
Enrollment
1,530 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT05849649 N/A
Recruiting
Mobile Application-based Exercise Intervention for Pregnant Women
Condition
Pregnancy Related
Enrollment
176 pts
Location
United States
Sponsor
Western Kentucky University
View Trial →
NCT01524276 N/A
Recruiting
Product Surveillance Registry
Condition
Cardiac Rhythm Disorders
Enrollment
100,000 pts
Location
United States, Argentina, Australia
Sponsor
Medtronic
View Trial →
NCT06024304 N/A
Recruiting
InterTAN: Integrated Dual Screw Design Improve Biomechanics/Function Following F...
Condition
Fracture of Hip
Enrollment
30 pts
Location
United States
Sponsor
Paul E. Matuszewski
View Trial →
NCT07507643 Phase 3
Recruiting
A Study of Methylprednisolone in People Having Liver Surgery
Condition
Hepatectomy
Enrollment
750 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
View Trial →
NCT05778188 Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary ...
Condition
Hypoxic-Ischemic Encephalopathy
Enrollment
70 pts
Location
United States
Sponsor
ReAlta Life Sciences, Inc.
View Trial →
NCT05180253 N/A
Recruiting
Esophageal and Gastric Registry and Biorepository
Condition
Gastro Esophageal Reflux
Enrollment
40 pts
Location
United States
Sponsor
University of Louisville
View Trial →
NCT06619561 Phase 2
Recruiting
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host ...
Condition
Chronic Graft-Versus-Host Disease (cGVHD)
Enrollment
48 pts
Location
United States
Sponsor
Deciphera Pharmaceuticals, LLC
View Trial →
NCT05920356 Phase 3
Recruiting
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab P...
Condition
Non-Small Cell Lung Cancer (NSCLC)
Enrollment
750 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
View Trial →
Page 1 of 7 — 163 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology